Sinpoharm-backed joint venture Sinopharm-CICC was among the investors in a $43.2m round that boosted the antimicrobial drug developer's total funding to near $150m.

The mental well-being and recruitment services provider has launched an investment vehicle that will provide up to $950,000 per deal.

The UK regional tech transfer alliance's Seed Investment Fund expects to close its first investments in coming months, targeting sectors including healthcare and data.

Osage University Partners-backed PMV has pushed its funding total to $236m as it further commercialises Princeton research stretching back to 1979.

Pfizer, Sanofi, Vertex Pharmaceuticals, Merck & Co and Amgen are in line for exits after the immunotherapy developer filed to go public.

Existing investor Hikma Ventures returned for a series B round that came amidst increased demand for Lemonaid's remote healthcare services.

Biocon's biosimilar subsidiary is valued at $3.5bn in the deal, which will involve Tata Capital acquiring a stake sized at under 1%.

Nestlé is the main backer of the consumer investment firm's latest fund, which has a $150m target for its final close.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

UCL Technology Fund 2 has achieved a first close on the way to its $131m target, with a cornerstone investment from UCL itself.